======= ATOH8 ======= == Gene Information == * **Official Symbol**: ATOH8 * **Official Name**: atonal bHLH transcription factor 8 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=84913|84913]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96SQ7|Q96SQ7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ATOH8&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ATOH8|Open PubMed]] * **OMIM**: [[https://omim.org/entry/619820|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Transcription factor that binds a palindromic (canonical) core consensus DNA sequence 5'-CANNTG- 3' known as an E-box element, possibly as a heterodimer with other bHLH proteins (PubMed:24236640). Regulates endothelial cell proliferation, migration and tube-like structures formation (PubMed:24463812). Modulates endothelial cell differentiation through NOS3 (PubMed:24463812). May be implicated in specification and differentiation of neuronal cell lineages in the brain (By similarity). May participate in kidney development and may be involved in podocyte differentiation (By similarity). During early embryonic development is involved in tissue-specific differentiation processes that are dependent on class II bHLH factors and namely modulates the differentiation program initiated by the pro-endocrine factor NEUROG3 (By similarity). During myogenesis, may play a role during the transition of myoblasts from the proliferative phase to the differentiation phase (By similarity). Positively regulates HAMP transcription in two ways, firstly by acting directly on the HAMP promoter via E-boxes binding and indirectly through increased phosphorylation of SMAD protein complex (PubMed:24236640). Repress NEUROG3-dependent gene activation in a gene-specific manner through at least two mechanisms; requires only either the sequestering of a general partner such as TCF3 through heterodimerization, either also requires binding of the bHLH domain to DNA via a basic motif (By similarity). {ECO:0000250|UniProtKB:Q99NA2, ECO:0000269|PubMed:24236640, ECO:0000269|PubMed:24463812}. |HLH| |myoblast proliferation| |positive regulation of endothelial cell differentiation| |positive regulation of pri-miRNA transcription by RNA polymerase II| |activating transcription factor binding| |regulation of endothelial cell differentiation| |negative regulation of endothelial cell proliferation| |regulation of pri-miRNA transcription by RNA polymerase II| |E-box binding| |SMAD protein signal transduction| |positive regulation of epithelial cell differentiation| |positive regulation of endothelial cell migration| |formation of primary germ layer| |negative regulation of epithelial cell proliferation| |regulation of endothelial cell proliferation| |positive regulation of epithelial cell migration| |regulation of epithelial cell differentiation| |tube formation| |regulation of endothelial cell migration| |gastrulation| |protein dimerization activity| |transmembrane receptor protein serine/threonine kinase signaling pathway| |regulation of epithelial cell migration| |regulation of epithelial cell proliferation| |nuclear speck| |positive regulation of cell migration| |positive regulation of cell motility| |positive regulation of cellular component movement| |positive regulation of locomotion| |cell population proliferation| |embryonic morphogenesis| |tube morphogenesis| |negative regulation of cell population proliferation| |DNA-binding transcription factor activity| |enzyme linked receptor protein signaling pathway| |tube development| |regulation of cell migration| |anatomical structure formation involved in morphogenesis| |regulation of cell motility| |positive regulation of cell differentiation| |embryo development| |regulation of locomotion| |regulation of cellular component movement| |negative regulation of transcription, DNA-templated| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |positive regulation of developmental process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of cell population proliferation| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 7282 * **Expression level (log2 read counts)**: -5.6 {{:chemogenomics:nalm6 dist.png?nolink |}}